Delivery Order SPE2DR25D9207-SPE2DR26FHDA2

The Defense Logistics Agency awarded a $2,518.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the company competed on an unrestricted basis. DMS Pharmaceutical Group is performing work under its larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense medical facilities.

As an established supplier within the Defense Logistics Agency's Medical Supply Chain division, DMS Pharmaceutical Group has demonstrated consistent performance across multiple therapeutic categories and product lines, ranging from routine medications to specialty pharmaceuticals and biologics. The PPV-G GEN V contract, which carries a $500 million ceiling and extends through December 2036, authorizes the company to serve as a critical pharmaceutical supplier for military healthcare operations globally. This individual delivery order for yellow fever vaccine represents one of numerous orders issued to the company under this broader prime vendor framework, supporting the recurring medical supply requirements of Department of Defense healthcare facilities.